Finance

Beta
Lists
PHR:NYSE
Phreesia Inc
$9.29
-0.54%
(-0.050) 1D
$9.29
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHR...
Open
$9.22
High
$9.64
Low
$9.12
Mkt. cap
574.23M
Avg. vol.
1.60M
Volume
0.00
P/E ratio
62.43
52-wk high
$32.76
52-wk low
$7.77
EPS
$0.15
Beta
0.91
Shares outstanding
61.81M
No. of employees
2K
Open
$9.22
High
$9.64
Low
$9.12
Mkt. cap
574.23M
Avg. vol.
1.60M
Volume
0.00
P/E ratio
62.43
52-wk high
$32.76
52-wk low
$7.77
EPS
$0.15
Beta
0.91
Shares outstanding
61.81M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 18 analysts giving stock ratings to PHR in the past 3 months
Buy
Buy
10
Hold
8
Sell
0
12 month forecast
Based on 18 Wall Street analysts offering 12 month price targets for PHR in the last 3 months.
Highest
Current $9.29
$20.00 (+115.29%)
Average
$14.33 (+54.25%)
Lowest
$9.00 (-3.12%)
News stories
From sources across the web
Yahoo! Finance Canada
Yahoo! Finance Canada
·
18 hours ago
Are Investors Undervaluing Phreesia (PHR) Right Now?
Profile
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake. Wikipedia
About Phreesia Inc
CEOChaim Indig
Employees1.79K
Founded2005
HeadquartersWilmington, Delaware, United States
SectorHealth care
Last report
May 27, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$0.19 / $0.29
-35.09%miss
Revenue / Est. (USD)
130.94M / 130.07M
+0.66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
117.26M
120.33M
127.07M
130.94M
Cost of goods sold
37.64M
38.03M
40.39M
43.33M
Cost of revenue
37.64M
38.03M
40.39M
43.33M
Research and development expenses
29.27M
29.45M
30.92M
28.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.44M
39.66M
44.37M
42.57M
Operating expense
81.12M
76.59M
84.98M
80.85M
Total operating expenses
118.76M
114.62M
125.37M
124.19M
Operating income
-1.51M
5.71M
1.69M
6.75M
Other non operating income
336.00K
1.01M
1.27M
-7.00K
EBT including unusual items
-563.00K
5.12M
-10.32M
4.72M
EBT excluding unusual items
-563.00K
7.10M
-2.57M
4.74M
Income tax expense
-1.22M
854.00K
-11.62M
1.76M
Effective tax rate
216.16%
16.66%
112.54%
37.26%
Other operating expenses
-
-
-
-
Net income
654.00K
4.27M
1.30M
2.96M
Net profit margin
0.56%
3.55%
1.02%
2.26%
Earnings per share
0.27
0.31
0.44
0.19
Interest and investment income
999.00K
700.00K
269.00K
297.00K
Interest expense
-391.00K
-320.00K
-5.81M
-2.30M
Net interest expenses
608.00K
380.00K
-5.54M
-2.00M
Depreciation and amortization charges
3.28M
3.20M
3.51M
3.37M
EBITDA
2.64M
13.19M
7.67M
12.73M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more